Iodipamide Sodium
Generic Name: iodipamide sodium
Manufactured by BRACCO. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: IODIPAMIDE SODIUM (20%). Application: NDA009321.
Overview
Manufactured by BRACCO. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: IODIPAMIDE SODIUM (20%). Application: NDA009321.
Dosage
Available as injectable for injection use.
Related Medications
Fostamatinib
fostamatinib
11 DESCRIPTION Fostamatinib is a tyrosine kinase inhibitor. TAVALISSE is formulated with the disodium hexahydrate salt of fostamatinib, a phosphate prodrug that converts to its pharmacologically active metabolite, R406, in vivo . The chemical name for fostamatinib disodium hexahydrate is disodium (6-[[5-fluoro-2-(3,4,5-trimethoxyanilino) pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxo-pyrido[3,2-b][1,4]oxazin-4-yl)methyl phosphate hexahydrate.
Colon (suis), Intestine (suis)
colon (suis), intestine (suis)
PURPOSE: Provides specific sarcode support for the intestines.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Abroma Aug, Syzygium, Gymnema Sil, Aswagandha, Alfalfa, Aven Sat
abroma aug, syzygium, gymnema sil, aswagandha, alfalfa, aven sat
Uses Temporarily relieves occasional irritability, changes in appetite, weight loss, unusual thirst, vision problems (blurring), tiredness, pale skin color, numbness or tingling feeling in the hands or feet, chest discomfort, repeated issues or slow healing of wounds, genital/vaginal itching, constant headaches, and frequent urination.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or pr
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.